Achondroplasia, which affects around one in 20,000 babies, has just one approved treatment: BioMarin’s Voxzogo. However, new investigational treatments are vying to compete in the area.

The oral FGFR1-3 selective tyrosine kinase inhibitor infigratinib was found to be safe and effective at the highest studied dose among children with achondroplasia in a phase II dose-finding study.

Discover top medications for 'treating Achondroplasia'? This page compiles essential information on generic and brand-name drugs specifically used for Achondroplasia treatment.Here, you can ...

Francesca Mills has well and truly won over Silent Witness fans with her portrayal of crime analyst Kit Brooks, who joined ...

A promising daily tablet is effective at increasing height and improving proportional limb growth in children with achondroplasia, the most common form of dwarfism, according to a new study.

She said that she was motivated to front the upcoming programme after meeting her birth mother in a 2023 film for ITV.